Abeona Therapeutics Inc
ABEO
NASDAQ
Biotechnology
$5.99
USD
-0.36 (-5.67%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $363.91M
Volume 5.4M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SCTX | Scribe Therapeutics Inc | - | - | - | - | |
ABEO | Abeona Therapeutics Inc | $363.91M | 5.50 | - | - | |
STRO | Sutro Biopharma Inc | $360.08M | - | +49.9% | - | |
GALT | Galectin Therapeutics Inc | $356.00M | - | - | - | |
TLSI | TriSalus Life Sciences Inc | $351.59M | - | +39.6% | - | |
IPSC | Century Therapeutics Inc | $348.08M | - | - | - | |
SABS | SAB Biotherapeutics Inc | $345.75M | 26.05 | - | - | |
LYEL | Lyell Immunopharma Inc | $336.70M | - | -52.3% | - | |
IMRX | Immuneering Corp | $336.43M | - | - | - | |
IKT | Inhibikase Therapeutics Inc | $336.28M | - | - | - | |
AGEN | Agenus Inc | $315.14M | 4.88 | +24.5% | - |
Top Peer by Growth
Sutro Biopharma Inc
+49.9% YoY Revenue
Lowest P/E Ratio
Agenus Inc
4.88x P/E
Best 1-Year Return
Century Therapeutics Inc
+278.4% Return